Current Status of Rho-Associated Kinases (ROCKs) in Coronary Atherosclerosis and Vasospasm

Author(s): Ming Dong, Bryan P. Yan, Chuek-Man Yu

Journal Name: Cardiovascular & Hematological Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents)

Volume 7 , Issue 4 , 2009

Become EABM
Become Reviewer


Rho-kinase (ROCK) is one of the effectors of the small GTP-binding protein Rho. Accumulating evidence suggests that the Rho/ROCK system may play an important role in the pathogenesis of atherosclerosis and coronary vasospasm via its action in vascular smooth muscle cell contraction, endothelial function and the inflammatory process. Recent observations suggest that the beneficial cardiovascular effects of statins may, at least in part, derive from the inhibition of ROCKs. Fasudil is a ROCKs inhibitor which has potential benefits in coronary artery spasm and myocardial ischemia. In this review, we aim to describe the current understanding of ROCKs signaling and their roles in the pathophysiology of atherosclerosis and coronary spasm.

Keywords: Rho-kinase (ROCK), inhibitor, atheroscleorosis, kallikrein inhibitors, coronary spasm

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [322 - 330]
Pages: 9
DOI: 10.2174/187152509789541891
Price: $65

Article Metrics

PDF: 18